The Genetic Pathways Underlying Immunotherapy in Dilated Cardiomyopathy
<div><p>Heart failure (HF) is a global public health threat affecting 26 million individuals worldwide with an estimated prevalence increase of 46% by 2030. One of the main causes of HF and sudden death in children and adult is Dilated Cardiomyopathy (DCM). DCM is characterized by dilati...
Saved in:
| Main Author: | Ayat Kadhi (18281710) (author) |
|---|---|
| Other Authors: | Fathima Mohammed (18526749) (author), Georges Nemer (295984) (author) |
| Published: |
2021
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genetic evaluation of cardiomyopathies in Qatar identifies enrichment of pathogenic sarcomere gene variants and possible founder disease mutations in the Arabs
by: Kholoud N. Al‐Shafai (18459009)
Published: (2021) -
Takotsubo (stress) cardiomyopathy induced by acute asthma exacerbation in elderly woman
by: Khaled Al Khodari (21383186)
Published: (2023) -
An ophthalmologist with myocardial bridging developed takotsubo cardiomyopathy while operating; A case report and literature review
by: Anas Al‐sadi (17746794)
Published: (2023) -
Founder Mutation in N Terminus of Cardiac Troponin I Causes Malignant Hypertrophic Cardiomyopathy
by: Akl C. Fahed (11514346)
Published: (2020) -
Anthracyclines-Induced Vascular Endothelial Dysfunction in Cancer Patients and Survivors Using Brachial Flow-Mediated Dilation (FMD) Tool: A Systematic Review and Meta-Analysis
by: Lana A. Kattan (22466173)
Published: (2025)